- ►diabetesjournals.org B Charbonnel, J Dormandy, E Erdmann, M Massi- … - Diabetes Care, 2004 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—PROactive is an on-going randomized, double-blind
outcome study in patients with type 2 diabetes managed with diet and/or oral blood
glucose-lowering drugs (combination of oral agents with insulin is permitted) who have a ... Cited by 22 - Related articles - All 2 versions
B Charbonnel, J Dormandy, E Erdmann, M Massi- … - Diabetes Care, 2004 - ncbi.nlm.nih.gov OBJECTIVE: The PROspective pioglitAzone Clinical Trial In macroVascular Events
(PROactive) assesses the effect of pioglitazone, a peroxisome proliferator-activated receptor
agonist, with anti-inflammatory and vascular properties, on the secondary prevention of ... Cited by 112 - Related articles - BL Direct - All 3 versions
[CITATION] Marketing van primaire en secundaire eindpunten
N Freemantle - British Medical Journal, 2005 - bmj.com Last month, members of the steering committee of the prospective pioglitazone clinical trial in
macrovascular events (Proactive) presented the results at the European Association for the Study
of Diabetes meeting in Athens. 1 The audience, which overflowed from the meeting room, ... Cited by 51 - Related articles - BL Direct - All 9 versions
P Thorsby, B Kilhovd, R Sletmo, S Martinsen, … - TIDSSKRIFT-NORSKE …, 2000 - tidsskriftet.no Hyperglykemien ved type 2-diabetes skyldes redusert β -cellefunksjon og insulinresistens. Begge
disse tilstander er angrepspunkter ved behandlingen. Målet med den blodsukkersenkende behandling
ved type 2-diabetes er å eliminere symptomer på hyperglykemi og å redusere risikoen for ... Cited by 4 - Related articles - Cached - BL Direct - All 4 versions
[CITATION] Silent myocardial ischemia in patients with diabetes
C Le Feuvre - Presse médicale (Paris, France: 1983), 2004 - ncbi.nlm.nih.gov PROVEN EFFICACY: Since their launch on the French market in 2002, thiazolidinediones
("glitazones") prescribing conditions and therapeutic indications have progressively
widened, although remaining strictly defined by the marketing licence. Clinical efficacy on ... Cited by 6 - Related articles - BL Direct
[CITATION] Arterial Revascularisation Therapies Study part II Steering Committee and …
